Achilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 20, 2022

https://www.globenewswire.com/news-release/2022/12/20/2577065/0/en/Achilles-Therapeutics-to-Present-at-the-41st-Annual-J-P-Morgan-Healthcare-Conference.html

LONDON, Dec. 20, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that Dr. Iraj Ali, Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 8:15 am PST. The event will be held at the Westin St. Francis Hotel in San Francisco, California.

Read more at globenewswire.com

Related news for (ACHL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.